The goal of this observational study is to identify differential traits in spontaneous migraine attacks that can help us predict the response to treatment with sumatriptan.
Participants will be asked to register the headache characteristics before and after taking sumatriptan and whether the treatment was effective or not during four migraine attacks.
Migraine with or without aura diagnosis according to ICHD-3 criteria
<8 migraine days per month
Be able to read, write and understand instructions.
Have internet access and mail address
Active preventive treatment for migraine
Active medication with an effect over the central nervous system
Serious physical or psychiatric condition
Cardiovascular or hepatic disease
Otherwise healthy episodic migraine patients.
Case-only
Prospective
Sumatriptan
DrugRegister the response to treatment and headache characteristics.
Response to sumatriptan
Relief of pain from moderate-severe to mild or absent at 2 hours and 24 hours in 3 out of 4 migraine attacks. The response will be evaluated via questionnaire.
Migraine characteristics
Patients will complete a questionnaire describing the characteristics of migraine attacks in the beginning of the attack, and at timepoints 2 and 24 hours after taking sumatriptan.
Click on the lead sponsor to view all of their trials.
Hospital Universitari Vall d'Hebron Research Institute
Lead sponsor
Instituto de Salud Carlos III
Collaborator
